X Xie1, M McGregor, N Dendukuri. 1. Department of Medicine, I McGill University Health Centre, Montreal, Quebec, Canada.
Abstract
OBJECTIVE: To estimate the efficacy of negative pressure wound therapy (NPWT), on the basis of a systematic review of reported randomised controlled trials (RCTs). METHOD: A systematic literature search for relevant RCTs was carried out. The credibility of the outcome of each study was evaluated using a specially constructed instrument. RESULTS: We identified 17 RCTs, of which five had not been included in previous reviews or health technology assessments. For diabetic foot ulcers (seven RCTs), there was consistent evidence of the benefit of NPWT compared with control treatments. For pressure ulcers (three RCTs), results were conflicting. In trials involving mixed wounds (five RCTs), evidence was encouraging but of inadequate quality. Significant complications were not increased. CONCLUSION: There is now sufficient evidence to show that NPWT is safe, and will accelerate healing, to justify its use in the treatment of diabetes-associated chronic leg wounds. There is also evidence, though of poor quality, to suggest that healing of other wounds may also be accelerated.
OBJECTIVE: To estimate the efficacy of negative pressure wound therapy (NPWT), on the basis of a systematic review of reported randomised controlled trials (RCTs). METHOD: A systematic literature search for relevant RCTs was carried out. The credibility of the outcome of each study was evaluated using a specially constructed instrument. RESULTS: We identified 17 RCTs, of which five had not been included in previous reviews or health technology assessments. For diabetic foot ulcers (seven RCTs), there was consistent evidence of the benefit of NPWT compared with control treatments. For pressure ulcers (three RCTs), results were conflicting. In trials involving mixed wounds (five RCTs), evidence was encouraging but of inadequate quality. Significant complications were not increased. CONCLUSION: There is now sufficient evidence to show that NPWT is safe, and will accelerate healing, to justify its use in the treatment of diabetes-associated chronic leg wounds. There is also evidence, though of poor quality, to suggest that healing of other wounds may also be accelerated.
Authors: Amy L Strong; Annie C Bowles; Connor P MacCrimmon; Trivia P Frazier; Stephen J Lee; Xiying Wu; Adam J Katz; Barbara Gawronska-Kozak; Bruce A Bunnell; Jeffrey M Gimble Journal: Stem Cells Transl Med Date: 2015-04-21 Impact factor: 6.940
Authors: Paolo Limongelli; Giuseppina Casalino; Salvatore Tolone; Luigi Brusciano; Giovanni Docimo; Gianmattia Del Genio; Ludovico Docimo Journal: Int Wound J Date: 2017-03-01 Impact factor: 3.315
Authors: Christopher Ward; David Ciraulo; Michael Coulter; Steven Desjardins; Lucy Liaw; Sarah Peterson Journal: J Trauma Acute Care Surg Date: 2012-08 Impact factor: 3.313